Morningstar

U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic ...

U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic Lymphoma -- Breakthrough ...
Morningstar

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell ...

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma ...

Bainbridge Middle School chorus honors student who died of cancer

Bainbridge Middle School chorus honors student who died of cancer ...
Medical Xpress

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that arises from the malignant transformation of T-cell progenitors. This disease is most commonly diagnosed in children, ...
Hosted on MSN

Parents Watch 11-Year-Old Son 'Slowly Fade Away' After Rare Chemo Complication Steals His Ability to Speak and Move (Exclusive)

River Brennan couldn't wait to start middle school, but after his lymphoma diagnosis, doctors said he would miss the entire year River Brennan was diagnosed with T-cell lymphoblastic lymphoma the ...
Medical Xpress

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Scientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their new simplified approach selected for an advantageous T-cell type and showed ...